Health In Tech, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $37.6M | $19.6M | $19.2M | — |
| Research and development | $1.6M | $2.8M | $2.0M | — |
| Operating expenses | $19.4M | $14.4M | $13.5M | — |
| Interest expense | — | $495,000 | $2,052 | — |
| Pretax income | $1.7M | $889,000 | $3.4M | — |
| Income tax expense | $395,330 | $218,523 | $945,236 | — |
| Net income | $1.3M | $670,477 | $4.0M | — |
| Balance Sheet | ||||
| Cash and equivalents | $7.7M | $7.8M | $2.4M | — |
| Current assets | $16.2M | $10.8M | $6.9M | — |
| Total assets | $23.1M | $15.8M | $11.5M | — |
| Current liabilities | $5.2M | $2.1M | $4.8M | — |
| Total liabilities | $6.0M | $2.6M | $5.4M | — |
| Stockholders' equity | $17.1M | $13.2M | $6.1M | $1.4M |
| Cash Flow Statement | ||||
| Cash from operations | $3.1M | $2.2M | $1.5M | — |
| Depreciation and amortization | $900,577 | $541,141 | $339,300 | — |
| Stock-based compensation | $1.6M | $468,489 | — | — |
| Impairments | $0 | $0 | — | — |
Shares outstanding 65.5M
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.